| Date | Title | | | 12/02/08 | Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference| CARLSBAD, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq:
GXDX), a specialized laboratory services provider, today announced the
Company's participation at the RBC Capital Markets 2008 Healthcare Conference
scheduled to take place at the Westin New York Hotel at Times Square on
December 10-11, 2008.
Sam Riccitelli, COO and executive vice president of Genoptix, will take
part in a panel discussion at the conference on Wednesday, December 10,
beginning at approximat... |
|  | | 11/25/08 | Genoptix Announces Participation at the Twentieth Annual Piper Jaffray Healthcare Conference| CARLSBAD, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the Company's participation at the Twentieth Annual Piper Jaffray Healthcare
Conference scheduled to take place at the New York Palace Hotel in New York
City on December 2-3, 2008.
Dr. Tina S. Nova, CEO and President of Genoptix, will present at the
conference on Wednesday, December 3, beginning at approximately 2:00 p.m. EST.
Dr. Nova will... |
| | | 11/12/08 | Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloitte's 2008 Technology Fast 500| Company To Ring Opening Bell At Nasdaq On November 14th
CARLSBAD, Calif., Nov. 12 /PRNewswire-FirstCall/ -- (Nasdaq: GXDX), a
specialized laboratory services provider, today announced it has been ranked
number nine on Deloitte's 2008 Technology Fast 500, a ranking of the 500
fastest-growing technology, media, telecommunications and life sciences
companies in North America. Rankings are based on the percentage of fiscal
year revenue growth over five years, from 2003-2007. G... |
| | | 11/06/08 | Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008| Company Reports Seventeenth Consecutive Quarter Of Growth In Revenues
CARLSBAD, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today reported
revenues of $32.1 million for the third quarter of 2008, which includes a $2.5
million benefit from changes in accounting estimates relating to prior
periods. This compares to revenues of $16.2 million for the same period in
2007, including $612 thousand from changes in pri... |
| | | 10/23/08 | Genoptix, Inc. to Announce Third Quarter 2008 Financial Results| CARLSBAD, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a provider of personalized diagnostic services, announced
today that it expects to report its financial results for the third quarter
after closing of the NASDAQ Global Market on Thursday, November 6, 2008.
A conference call hosted by President and CEO, Dr. Tina S. Nova, and other
members of senior management will take place on the same day at 2:00pm PST
(5:00pm EST) and will be webcast live on the... |
| | | 10/22/08 | Genoptix Announces Participation at the BIOCOM Investor Conference 2008| CARLSBAD, Calif., Oct. 22 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the Company's participation at the BIOCOM Investor Conference 2008 scheduled
to take place at the Hyatt Regency in La Jolla, CA on October 26-28, 2008.
Dr. Tina Nova, President and CEO of Genoptix, will present at the
conference on Monday, October 27, beginning at approximately 9:30 a.m. PDT.
Dr. Nova will provide an overview of the Company'... |
| | | 10/13/08 | Genoptix Ranked Fastest Growing Company in San Diego in Deloitte's Technology Fast 50 Awards Program| CARLSBAD, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced it has been named the fastest growing company in Deloitte's prestigious Technology Fast 50 Program for San Diego, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area by Deloitte LLP, one of the nation's leading professional services organizations. Rankings are based on the percentage revenue gr... |
| | | 09/30/08 | Genoptix Announces Participation at the Second Annual William Blair Small Cap Growth Conference| CARLSBAD, Calif., Sept. 30 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the Company's participation at the Second Annual William Blair Small Cap
Growth Conference scheduled to take place at the Waldorf-Astoria Hotel in New
York City on October 7 - 8, 2008.
Douglas Schuling, Senior Vice President and CFO of Genoptix, will present
at the conference on Tuesday, October 7, beginning at approximately 10:00 a.m.
E... |
| | | 09/16/08 | Genoptix Announces Participation at the UBS Global Life Sciences Conference| CARLSBAD, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the Company's participation at the UBS Global Life Sciences Conference
scheduled to take place at the Grand Hyatt in New York City on September 22 -
25, 2008.
Douglas Schuling, Senior Vice President and CFO of Genoptix, will present
at the conference on Monday, September 22, beginning at approximately 3:30 pm
EDT. Mr. Schuling will provid... |
| | | 08/27/08 | Genoptix Announces Participation at the 2008 Southern California Investor Conference| CARLSBAD, Calif., Aug 27, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the Company's participation at the 2008 Southern California Investor
Conference scheduled to take place at The Islands Hotel in Newport Beach, CA
on September 3, 2008.
Sam Riccitelli, Executive Vice President and COO of Genoptix, will present
at the conference on that Wednesday, beginning at approximately 8:30 am, PDT.
... |
| | | 08/01/08 | Genoptix Announces the Addition of New Members to Board of Directors| CARLSBAD, Calif., Aug 01, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, announced the
election of Karin Eastham and Laurence R. McCarthy, Ph.D. to its Board of
Directors, effective as of July 30, 2008. Ms. Eastham has been elected to
serve as a Class I director of Genoptix until the 2011 Annual Meeting of
Stockholders and will also serve on the Audit Committee of the Board of
Directors. Dr. McCarthy has be... |
| | | 07/31/08 | Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008| CARLSBAD, Calif., July 31 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today reported
revenues of $27.8 million for the second quarter of 2008 and $50.1 million for
the first half of 2008, as compared to revenues of $13.9 million and
$24.6 million for the respective periods in 2007. Stated revenue for the
first half of 2008 included a $1.3 million benefit from changes in accounting
estimates relating to prior periods.
"Our s... |
| | | 07/21/08 | Genoptix, Inc. to Announce Second Quarter 2008 Financial Results| CARLSBAD, Calif., July 21 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a provider of personalized diagnostic services, announced
today that it expects to report its financial results for the second quarter
after closing of the NASDAQ Global Market on Thursday, July 31, 2008.
A conference call hosted by President and CEO Tina Nova Bennett, Ph.D. and
other members of senior management will take place on the same day at 2:00pm
PDT (5:00pm EDT) and will be webcast live on t... |
| | | 06/18/08 | Genoptix Announces Participation at the Jefferies Second Annual Healthcare Conference| CARLSBAD, Calif., June 18 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the Company's participation at the Jefferies Second Annual Healthcare
Conference scheduled to take place on June 24 - 26, 2008.
Douglas Schuling, Senior Vice President and CFO of Genoptix, will present
at the conference on Tuesday, June 24, 2008 beginning at approximately 3:15
pm, EDT. Mr. Schuling will provide an overview of the Company's ... |
| | | 05/08/08 | Genoptix Reports Strong Financial Results for First Quarter 2008| CARLSBAD, Calif., May 8 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory service provider, today reported
revenues of $22.3 million for the first quarter ended March 31, 2008, as
compared to revenues of $10.7 million for the comparable period in 2007. The
first quarter 2008 results include a $651 thousand benefit from changes in
accounting estimates relating to 2007.
"We started the year with another quarter of strong operational results,
increasi... |
| | | 04/30/08 | Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference| CARLSBAD, Calif., April 30 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the company's participation in the Bank of America 2008 Healthcare Conference
scheduled to take place at the Four Seasons Hotel in Las Vegas, Nev.,
May 13 - 15, 2008.
Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli,
COO, will present at the conference on Tuesday, May 13, 2008 beginning at
approximately 9:20am PDT. ... |
| | | 04/22/08 | Genoptix, Inc. to Announce First Quarter 2008 Financial Results| CARLSBAD, Calif., April 22 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a provider of personalized diagnostic services, announced
today that it expects to report its financial results for the first quarter
after closing of the NASDAQ Global Market on Thursday, May 8, 2008.
A conference call hosted by President and CEO Tina Nova Bennett, Ph.D. and
other members of senior management will take place on the same day at
2:00pm PDT (5:00pm EDT) and will be webcast live on the... |
| | | 04/02/08 | Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record| CARLSBAD, Calif., April 2, 2008 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX) today announced that the company's 2008 annual meeting of
stockholders is scheduled to be held at 9:00am PT on June 17, 2008 at the
company's headquarters in Carlsbad, CA.
The Genoptix board of directors has approved the close of business on
April 25, 2008 as the record date for the determination of the stockholders
who are entitled to notice of, and to vote at, the annual meeting.
About Ge... |
| | | 03/07/08 | Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference| CARLSBAD, Calif., March 7 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the company's participation in the 11th Annual Lehman Brothers Global Health
Care Conference at the Loews Miami Beach Hotel in South Beach, Fla.,
March 18 - 20, 2008.
Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli,
COO, will present at the conference on Tuesday, March 18, 2008 beginning at
approximately 10:45am EDT... |
| | | 03/06/08 | Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference| CARLSBAD, Calif., March 6, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the company's participation in the Cowen and Company 28th Annual Health Care
Conference at the Boston Marriott Copley Place Hotel in Boston, Mass.,
March 17 - 20, 2008.
Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli,
COO, will present at the conference on Monday, March 17, 2008 beginning at
ap... |
| | | 02/29/08 | Genoptix Announces Pricing of Secondary Public Offering| CARLSBAD, Calif., Feb. 29 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), today announced the pricing of 2,086,957 shares of outstanding
common stock being offered by certain existing stockholders to the public at
the price of $25.50 per share. Genoptix, Inc. will not receive any proceeds
from the sale. The offer is expected to close on March 5, 2008.
The offering is being made through an underwriting syndicate led by Lehman
Brothers, Inc. acting as sole book-running mana... |
| | | 02/14/08 | Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock| CARLSBAD, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), announced today that it has filed a registration statement
with the Securities and Exchange Commission for a proposed secondary public
offering of 4,200,000 shares of common stock. The shares of common stock to
be registered are currently owned and will be offered and sold by certain
existing stockholders, who will receive all of the net proceeds from this
offering. Genoptix, Inc. will not be selling a... |
| | | 02/12/08 | Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007| Annual Revenues Increase 147% In First Full-Year Of Profitability
CARLSBAD, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory service provider, today reported
revenues of $18.6 million for the fourth quarter ended December 31, 2007, an
increase of 137% over revenues of $7.8 million for the comparable period in
2006. For the full year ended December 31, 2007, the Company reported revenues
of $59.3 million, an increase of 147% ove... |
| | | 01/30/08 | Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008| CARLSBAD, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a provider of personalized diagnostic services, announced
today that it expects to report its financial results for the fourth quarter
and full-year 2007 after closing of the NASDAQ Global Market on
Tuesday, February 12, 2008.
A conference call hosted by President and CEO Tina Nova Bennett, Ph.D. and
other members of senior management will take place on the same day at 2:00pm
PST (5:00pm EST) and wi... |
| |
|
